EpiCypher, Tebu-bio Reach European Distribution Agreement | GenomeWeb

NEW YORK (GenomeWeb News) – Epigenetics tools firm EpiCypher today announced it has selected Tebu-bio as its distribution partner in Europe.

Tebu-bio will distribute Research Triangle Park, NC-based EpiCypher's epigenetics and chromatic biology research products. Tebu-bio is based in Le Perray, France and has offices in Belgium, Germany, Italy, the Netherlands, Denmark, Finland, Norway, Sweden, Portugal, Spain, and the UK.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genome sequencing study of Yakutian horses, tardigrade genome, and more.

A guest post at Retraction Watch discusses what funders can do to improve research reproducibility.

Researchers report in Nature this week that farming led to genomic adaptations in humans.

The FDA argues that it needs to evaluate the safety and efficacy of laboratory-developed tests, a proposal that divides Republicans.